Teleflex Incorporated (NYSE:TFX) Given Average Recommendation of “Hold” by Brokerages

Shares of Teleflex Incorporated (NYSE:TFX) have earned an average recommendation of “Hold” from the eight brokerages that are covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $140.8333.

TFX has been the topic of several analyst reports. Wells Fargo & Company raised their target price on Teleflex from $116.00 to $130.00 and gave the company an “equal weight” rating in a report on Friday, February 27th. Weiss Ratings restated a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Zacks Research downgraded shares of Teleflex from a “hold” rating to a “strong sell” rating in a research report on Monday, March 2nd. Truist Financial lifted their price objective on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research note on Thursday, December 18th. Finally, Wall Street Zen cut shares of Teleflex from a “hold” rating to a “sell” rating in a research report on Saturday, March 7th.

Teleflex Stock Performance

NYSE:TFX opened at $107.18 on Friday. Teleflex has a twelve month low of $100.18 and a twelve month high of $143.32. The firm has a market capitalization of $4.74 billion, a price-to-earnings ratio of -5.22, a PEG ratio of 0.67 and a beta of 0.87. The company has a current ratio of 2.54, a quick ratio of 2.01 and a debt-to-equity ratio of 0.81. The firm’s fifty day simple moving average is $108.74 and its 200 day simple moving average is $117.57.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 26th. The medical technology company reported $1.93 EPS for the quarter, missing the consensus estimate of $3.73 by ($1.80). Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The company had revenue of $569.00 million during the quarter, compared to analysts’ expectations of $912.57 million. During the same period last year, the business earned $3.89 earnings per share. The company’s revenue for the quarter was down 28.5% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities research analysts expect that Teleflex will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, March 6th will be paid a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, March 6th. This represents a $1.36 annualized dividend and a yield of 1.3%. Teleflex’s payout ratio is -6.62%.

Institutional Trading of Teleflex

Several large investors have recently modified their holdings of the business. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Teleflex by 57.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock worth $26,000 after acquiring an additional 77 shares in the last quarter. Banque Cantonale Vaudoise grew its stake in Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after purchasing an additional 113 shares in the last quarter. Hantz Financial Services Inc. increased its holdings in Teleflex by 40.5% during the 4th quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company’s stock worth $48,000 after purchasing an additional 113 shares during the last quarter. UMB Bank n.a. increased its holdings in Teleflex by 57.1% during the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 113 shares during the last quarter. Finally, Maryland State Retirement & Pension System raised its position in shares of Teleflex by 1.5% in the 4th quarter. Maryland State Retirement & Pension System now owns 8,652 shares of the medical technology company’s stock valued at $1,056,000 after purchasing an additional 129 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.